TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

LATEST NEWS

Recession Fears, Trade War, BlackRock, Jeffrey Epstein - 5 Things You Must Know
MARKETS

Recession Fears, Trade War, BlackRock, Jeffrey Epstein - 5 Things You Must Know

Pfizer's Long-Term Outlook Is Murky, Says UBS on Lowering Price Target
STOCKS

Pfizer To Combine Off-Patent Drug Division With Mylan

Mylan Posts Stronger-Than-Expected Third-Quarter Profit, Reiterates Forecast
STOCKS

Mylan Shares Surge Amid Reports of Off-Patent Drug Combination with Pfizer

Dow Ends Sharply Higher Ahead of Trump-Xi Meeting at G-20
MARKETS

Stocks End Slightly Higher in Cautious Trading Ahead of Federal Reserve Meeting

Pfizer's Long-Term Outlook Is Murky, Says UBS on Lowering Price Target
EARNINGS

Pfizer Nabs Array Biopharma in $11.4 Billion Takeover of Cancer Drug Specialist

Jim Cramer Breaks Down Uber, Salesforce, FAANG and the Federal Reserve - LIVE
JIM CRAMER

Nio, Hexo, Microsoft, Adobe: 'Mad Money' Lightning Round

Fed Should Take the Third Way: Cramer's 'Mad Money' Recap (Tuesday 12/18/18)
JIM CRAMER

Don't Get Complacent: Cramer's 'Mad Money' Recap (Tuesday 6/4/19)

Biotech Firm Sarepta Surges 40% on Positive Test Results
MARKETS

Array BioPharma Surges as Loss Is Narrower Than Expected

Five Rules for This Market Beast: Cramer's 'Mad Money' Recap (Tues 1/16/18)
JIM CRAMER

Cramer's 'Mad Money' Recap: This Isn't a Rally

STM Leaps to 9-Year High as Apple Supplier Beats Earnings Estimates
JIM CRAMER

STMicroelectronics, Intercept Pharmaceuticals: 'Mad Money' Lightning Round

Watch Out For the Dominoes That Fall: Cramer's 'Mad Money' Recap (Wed 9/20/17)
JIM CRAMER

Watch Out For the Dominoes That Fall: Cramer's 'Mad Money' Recap

Mesoblast Soars on Stem-Cell Treatment Data
STOCKS

Mirati Skyrockets On Positive Data - Biotech Movers

Mesoblast Soars on Stem-Cell Treatment Data
HEALTH

Biotech Movers: Celsion, Array, BeiGene

10 Highest-Paying Jobs in 2016 If All You Care About Is Money
HEALTH

Biotech Movers: Akari, Array, Amicus

Buy Bristol Myers
MERGERS AND ACQUISITIONS

Bristol-Myers Hookup Boosts Array BioPharma

Another Drop in Crude Oil Prices Pulls S&P 500 From Records
FUTURES

S&P 500, Nasdaq Winning Streaks in Jeopardy as Markets Pause to Digest Latest Highs

Another Drop in Crude Oil Prices Pulls S&P 500 From Records
FUTURES

Another Drop in Crude Oil Prices Pulls S&P 500 From Records

Bristol-Myers Stock
HEALTH

Biotech Movers: Array Shares Rise on Bristol-Myers Collaboration

NuStar Energy Stock Rating Hiked at Wells Fargo
FUTURES

Stock Futures Lower as Traders Return From Long Holiday Weekend

Biotech Movers: Lion Biotechnologies, XBiotech, Halozyme
HEALTH

Biotech Movers: Myriad Genetics, Spectrum Pharmaceuticals, Array BioPharma

Novartis' CAR-T Gene Therapy Receives FDA Approval
MERGERS AND ACQUISITIONS

How Far into the Drug Pipeline Should the FTC Reach?

If You Don't Buy These 5 Stocks Before Their Looming Breakout, It's Your Loss
STOCKS

Trading 5 Hot Charts Set to Break Out Soon for Profit

AMD Shares Plunge on Q3 Earnings and Revenue Miss
STOCKS

How to Trade Monday's Most Active Stocks - AMD, Esperion Therapeutics, Nokia and More

Mesoblast Soars on Stem-Cell Treatment Data
HEALTH

Biotech Premarket Movers: CytomX, Aevi, Esperion

What Tax Reform Means for PayPal's Bottom Line
JIM CRAMER

PaylPal, CH Robinson Worldwide, Texas Instruments: 'Mad Money' Lightning Round